印度人群精神分裂症GWAS发现烟酸代谢紊乱与风险关联
在印度人群中开展精神分裂症全基因组关联研究,纳入1321例患者、885名家族对照和886名无关对照。发现8q24.3位点rs10866912与精神分裂症全基因组显著关联,该位点调控NAPRT1表达,而NAPRT1编码烟酸代谢关键酶。结果提示rs10866912基因型与烟酸状态可能影响精神分裂症易感性和治疗。
要点
- 印度人群GWAS发现8q24.3位点rs10866912与精神分裂症关联(OR=1.27,P=4.35×10-8)。
- rs10866912直接调控脑皮质NAPRT1转录本丰度,风险等位基因A与NAPRT1下调相关。
- NAPRT1参与烟酸代谢,提示烟酸状态可能影响精神分裂症易感性和治疗。
核心结论
- rs10866912与精神分裂症全基因组显著关联,并调控NAPRT1表达,提示NAPRT1为新的易感基因。
- 鉴于NAPRT1在烟酸代谢中的作用及烟酸缺乏可诱发类精神分裂症症状,rs10866912基因型和烟酸状态可能影响精神分裂症易感性和治疗。
研究设计与样本
- 患者符合DSM-IV精神分裂症诊断标准,无关对照无个人或家族精神病史。
- 研究进行单核苷酸多态性与基因表达关联分析, recruitment于2001年1月1日开始,2018年2月28日完成,基因分型和分型分析仍在进行。
主要发现
- 研究人群包括1321例精神分裂症患者、885名家族对照和886名无关对照;患者平均(SD)年龄39.1(11.4)岁,52.7%为男性。
- 样本显示统一族裔、一定程度近亲婚配,物质滥用率极低。
- 发现染色体8q24.3位点rs10866912(等位基因A)与精神分裂症全基因组显著关联(OR=1.27,95%CI 1.17-1.38;P=4.35×10-8),并在精神分裂症精神病学基因组联盟2数据中获得支持(OR=1.04,95%CI 1.02-1.06;P=7.56×10-4)。
- 该位点经历自然选择,风险等位基因A频率从印度约72%下降至欧洲约43%。
- rs10866912直接改变脑皮质NAPRT1转录本丰度(标准化效应量0.79;95%CI 0.6-1.0;P=5.8×10-13);在印度淋巴母细胞系中,风险等位基因A与NAPRT1下调相关(AA:0.74,n=21;CC:1.56,n=17;P=.004)。
关键数值与推荐
- 精神分裂症与rs10866912关联:OR=1.27(95%CI 1.17-1.38),P=4.35×10-8。
- 精神病学基因组联盟2数据中rs10866912关联:OR=1.04(95%CI 1.02-1.06),P=7.56×10-4。
- rs10866912对脑皮质NAPRT1转录本丰度的标准化效应量:0.79(95%CI 0.6-1.0),P=5.8×10-13。
- 印度淋巴母细胞系中rs10866912基因型与NAPRT1表达:AA为0.74(n=21),CC为1.56(n=17),P=.004。
临床怎么用
- 目前证据尚不足以推荐常规检测rs10866912或烟酸状态用于精神分裂症风险评估。
- 临床可关注烟酸缺乏相关神经精神症状的识别,但不应据此改变精神分裂症诊疗。
局限性
- 基因分型和分型分析仍在进行,部分结果可能未最终确定。
- 斑马鱼数据仅为初步,需进一步验证。
- 样本来自印度特定人群,存在近亲婚配,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Genome-wide association studies (GWASs) in European populations have identified more than 100 schizophrenia-associated loci. A schizophrenia GWAS in a unique Indian population offers novel findings. OBJECTIVE: To discover and functionally evaluate genetic loci for schizophrenia in a GWAS of a unique Indian population. DESIGN, SETTING, AND PARTICIPANTS: This GWAS included a sample of affected individuals, family members, and unrelated cases and controls. Three thousand ninety-two individuals were recruited and diagnostically ascertained via medical records, hospitals, clinics, and clinical networks in Chennai and surrounding regions. Affected participants fulfilled DSM-IV diagnostic criteria for schizophrenia. Unrelated control participants had no personal or family history of psychotic disorder. Recruitment, genotyping, and analysis occurred in consecutive phases beginning January 1, 2001. Recruitment was completed on February 28, 2018, and genotyping and analysis are ongoing. MAIN OUTCOMES AND MEASURES: Associations of single-nucleotide polymorphisms and gene expression with schizophrenia. RESULTS: The study population included 1321 participants with schizophrenia, 885 family controls, and 886 unrelated controls. Among participants with schizophrenia, mean (SD) age was 39.1 (11.4) years, and 52.7% were male. This sample demonstrated uniform ethnicity, a degree of inbreeding, and negligible rates of substance abuse. A novel genome-wide significant association was observed between schizophrenia and a chromosome 8q24.3 locus (rs10866912, allele A; odds ratio [OR], 1.27 [95% CI, 1.17-1.38]; P = 4.35 × 10-8) that attracted support in the schizophrenia Psychiatric Genomics Consortium 2 data (rs10866912, allele A; OR, 1.04 [95% CI, 1.02-1.06]; P = 7.56 × 10-4). This locus has undergone natural selection, with the risk allele A declining in frequency from India (approximately 72%) to Europe (approximately 43%). rs10866912 directly modifies the abundance of the nicotinate phosphoribosyltransferase gene (NAPRT1) transcript in brain cortex (normalized effect size, 0.79; 95% CI, 0.6-1.0; P = 5.8 × 10-13). NAPRT1 encodes a key enzyme for niacin metabolism. In Indian lymphoblastoid cell lines, (risk) allele A of rs10866912 was associated with NAPRT1 downregulation (AA: 0.74, n = 21; CC: 1.56, n = 17; P = .004). Preliminary zebrafish data further suggest that partial loss of function of NAPRT1 leads to abnormal brain development. CONCLUSIONS AND RELEVANCE: Bioinformatic analyses and cellular and zebrafish gene expression studies implicate NAPRT1 as a novel susceptibility gene. Given this gene's role in niacin metabolism and the evidence for niacin deficiency provoking schizophrenialike symptoms in neuropsychiatric diseases such as pellagra and Hartnup disease, these results suggest that the rs10866912 genotype and niacin status may have implications for schizophrenia susceptibility and treatment.
引用
- Periyasamy S, John S, Padmavati R, et al. Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study. JAMA Psychiatry. 2019. PMID: 31268507. doi:10.1001/jamapsychiatry.2019.1335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。